Literature DB >> 3007501

Metabolism of leukotriene B4 in isolated rat hepatocytes. Identification of a novel 18-carboxy-19,20-dinor leukotriene B4 metabolite.

T W Harper, M J Garrity, R C Murphy.   

Abstract

Isolated rat heptocytes were found to metabolize leukotriene B4 (LTB4) to a number of products which could be separated by reverse phase high performance liquid chromatography (HPLC). After incubation of LTB4 with hepatocytes for 15 min, the known omega-oxidized metabolites, 20-hydroxy- and 20-carboxy-LTB4, were identified by HPLC retention time and gas chromatography-mass spectrometry. An early fraction corresponding to 15% of the initial LTB4 was structurally characterized as a novel metabolite, 18-carboxy-19,20-dinor-LTB4, by ultraviolet spectroscopy and gas chromatography-mass spectrometry of the derivatized and derivatized, reduced metabolite. The short HPLC retention time of this metabolite was consistent with its reduced lipophilicity. An additional minor metabolite was tentatively identified as 3-hydroxy-LTB4. These two novel metabolites provide evidence for beta-oxidation as an important route of hepatic biotransformation of LTB4 and 20-hydroxy-LTB4.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007501

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Cellular communication inside the liver. Binding, conversion and metabolic effect of prostaglandin D2 on parenchymal liver cells.

Authors:  J Kuiper; F J Zijlstra; J A Kamps; T J Van Berkel
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  Novel mechanism of LTB4 metabolism in the guinea pig polymorphonuclear leukocyte.

Authors:  W Pickett; C Dondero; D Nytko; C Ramesha
Journal:  Agents Actions       Date:  1987-08

Review 3.  [The Heinrich-Wieland Prize presentation. Metabolism and analysis of leukotrienes in vivo].

Authors:  D Keppler
Journal:  Klin Wochenschr       Date:  1988-10-17

4.  The immunosuppressive effects of a leukotriene B4 receptor antagonist on liver allotransplantation in rats.

Authors:  T Ii; R Izumi; K Shimizu
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

5.  Hepatic uptake and metabolic disposition of leukotriene B4 in rats.

Authors:  W Hagmann; M Korte
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

6.  Metabolism of leukotriene B4 by activated human polymorphonuclear granulocytes.

Authors:  J Brom; W Schönfeld; W König
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

7.  Novel 3-hydroxylated leukotriene b4 metabolites from ethanol-treated rat hepatocytes.

Authors:  M A Shirley; R C Murphy
Journal:  J Am Soc Mass Spectrom       Date:  1992-10       Impact factor: 3.109

8.  Analysis of leukotriene B4 metabolism in human promyelocytic HL-60 cells.

Authors:  S Kasimir; W Schönfeld; R A Hilger; W König
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

9.  Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

Authors:  E Mayatepek; W D Lehmann; J Fauler; D Tsikas; J C Frölich; R B Schutgens; R J Wanders; D Keppler
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Constitutive androstane receptor agonist, TCPOBOP, attenuates steatohepatitis in the methionine choline-deficient diet-fed mouse.

Authors:  Edwina-S Baskin-Bey; Akira Anan; Hajime Isomoto; Steven-F Bronk; Gregory-J Gores
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.